Skip to main content
. 2022 Jan 3;207(3):351–359. doi: 10.1093/cei/uxab037

Table 5.

Percentage of CD28null CD8+ T and NKT-like cells producing interferon gamma (IFNγ) and tumour necrosis factor alpha (TNF α) in blood, BAL, SA, and LA from patients with the COPD and control subjects

COPD T cells NKT-like cells
CD28null CD8+ CD28null CD8+
IFNγ TNFα IFNγ TNFα
Blood ^55 (38–63)# ^58 (42–66) ^61 (36–71) ^66 (38–73)
 BAL ^62 (42–76) ^59 (39–73) ^67 (48–91) ^69 (41–78)
 LA ^72 (54–92) ^67 (51–88) ^74 (42–79) ^78 (52–84)
 SA ^86 (69–98)@ ^92 (72–97)@ ^88 (71–99)@ ^91 (69–96)@
Control T cells NKT-like cells
CD28null CD8+ CD28nullCD8+
IFNγ TNFα IFNγ TNFα
Blood 34 (18–42) 36 (20–45) 36 (23–44) 35 (16–48)
 BAL 33 (13–46) 33 (12–33) 36 (18–53) 36 (13–46)
 LA 31 (12–43) 39 (14–41) 33 (16–47) 37 (13–51)
 SA 38 (22–53) 31 (12–38) 42 (25–62) 30 (11–40)

There was a significant increase in CD28null CD8+ T and NKT-like cells producing IFNγ and TNFα in blood, BAL, SA, and LA from patients with the COPD compared with control subjects. There was a significant increase in CD28null CD8+ T and NKT-like cells producing IFNγ and TNFα in SA compared with blood, BAL, and LA from patients with the COPD.

Median (range).

Significantly increased compared with control (P < 0.05 for all).

Significantly increased compared with blood, BAL and LA (P < 0.05 for all).